Effects of Human Amniotic-derived Mesenchymal Stem Cells (hAMSCs) on Calciphylaxis Patients: An Open-Label Single-Arm Study
Chronic Kidney Diseases · Calciphylaxis · Calcific Uremic Arteriolopathy
Enrolment: 9 · Results not recorded
Biologic
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Chronic Kidney Diseases · Calciphylaxis · Calcific Uremic Arteriolopathy
Enrolment: 9 · Results not recorded
Inflammatory Bowel Diseases
Enrolment: 40 · Results not recorded
Amyotrophic Lateral Sclerosis · Multiple Sclerosis
Enrolment: 60 · Results not recorded
Supraspinatus Tear
Enrolment: 24 · Results not recorded
Brachial Plexus Neuropathies
Enrolment: 24 · Results not recorded
Knee Osteoarthritis
Enrolment: 60 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Lung injury induced by 5 minutes of white smoke inhalation from an ignited smoke pot in a purpose-built smoke exposure apparatus
hAMSCs localised mainly to lung tissue and progressively declined over 28 days. Compared with model and PBS groups, hAMSC treatment reduced the CT score, wet/dry weight ratio, histological lung injury score and lung fibrosis, increased PaO2 and PaO2/FiO2 and lowered PaCO2, increased SP-A, SP-C and…
Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.